DELiver Therapeutics
Houston, US · 1 known investors
DELiver Therapeutics develops small molecule and peptide therapeutics using high-throughput DNA encoded library (DEL) drug screening to address challenging and previously "undruggable" targets in clinical medicine, with a focus on tyrosine kinase targets. Its R&D facilities are located at K2Bio in Houston.
Founders & leadership
KS
Investors · 1
Frequently asked questions
- What does DELiver Therapeutics do?
- DELiver Therapeutics develops small molecule and peptide therapeutics using high-throughput DNA encoded library (DEL) drug screening to address challenging and previously "undruggable" targets in clinical medicine, with a focus on tyrosine kinase targets. Its R&D facilities are located at K2Bio in Houston.
- Who founded DELiver Therapeutics?
- DELiver Therapeutics was founded by Kevin Slawin.
- Who are DELiver Therapeutics's investors?
- DELiver Therapeutics's investors include Rapha Capital Management, LLC.
- Where is DELiver Therapeutics headquartered?
- DELiver Therapeutics is headquartered in Houston, US.